Rezultati - Stevenson, James M

Insights and barriers to clinical use of serotonin transporter pharmacogenetics in antidepressant therapy od Stevenson, James M

Polni tekst Polni tekst Polni tekst

Risk Factors for Cardiovascular Events in Patients on Antidementia Medications od He, Meiqi, Stevenson, James M., Zhang, Yuting, Hernandez, Inmaculada

Polni tekst Polni tekst Polni tekst

Projected Utility of Pharmacogenomic Testing Among Individuals Hospitalized With COVID‐19: A Retrospective Multicenter Study in the United States od Stevenson, James M., Alexander, G. Caleb, Palamuttam, Natasha, Mehta, Hemalkumar B.

Polni tekst Polni tekst Polni tekst

Pharmacogenetics: A Precision Medicine Approach to Combatting the Opioid Epidemic od Smith, D. Max, Stevenson, James M., Ho, Teresa T., Formea, Christine M., Gammal, Roseann S., Cavallari, Larisa H.

Polni tekst Polni tekst Polni tekst

Echinacea Purpurea Significantly Induces Cytochrome P450 3A (CYP3A) but does not alter Lopinavir-Ritonavir Exposure in Healthy Subjects od Penzak, Scott R., Robertson, Sarah M., Hunt, Jennifer D., Chairez, Cheryl, Malati, Christine Y., Alfaro, Raul M., Stevenson, James M., Candidate, Pharm.D., Kovacs, Joseph A.

Polni tekst Polni tekst Polni tekst

Evaluating the Extent of Reusability of CYP2C19 Genotype Data among Patients Genotyped for Antiplatelet Therapy Selection od Beitelshees, Amber L., Stevenson, James M., El Rouby, Nihal, Dillon, Chrisly, Empey, Philip E., Fielstein, Elliot M., Johnson, Julie A., Limdi, Nita A., Ong, Henry H., Franchi, Francesco, Angiolillo, Dominick P., Peterson, Joshua F., Rosenman, Marc B., Skaar, Todd C., Tuteja, Sony, Cavallari, Larisa H.

Polni tekst Polni tekst Polni tekst

Genome-wide association study accounting for anticholinergic burden to examine cognitive dysfunction in psychotic disorders od Eum, Seenae, Hill, S. Kristian, Alliey-Rodriguez, Ney, Stevenson, James M., Rubin, Leah H., Lee, Adam M., Mills, Lauren J., Reilly, James L., Lencer, Rebekka, Keedy, Sarah K., Ivleva, Elena, Keefe, Richard S. E., Pearlson, Godfrey D., Clementz, Brett A., Tamminga, Carol A., Keshavan, Matcheri S., Gershon, Elliot S., Sweeney, John A., Bishop, Jeffrey R.

Polni tekst Polni tekst Polni tekst

Impact of the CYP2C19*17 allele on outcomes in patients receiving genotype-guided antiplatelet therapy after percutaneous coronary intervention od Lee, Craig R., Thomas, Cameron D., Beitelshees, Amber L., Tuteja, Sony, Empey, Philip E., Lee, James C., Limdi, Nita A., Duarte, Julio D., Skaar, Todd C., Chen, Yiqing, Cook, Kelsey J., Coons, James C., Dillon, Chrisly, Franchi, Francesco, Giri, Jay, Gong, Yan, Kreutz, Rolf P., McDonough, Caitrin W., Stevenson, James M., Weck, Karen E., Angiolillo, Dominick J., Johnson, Julie A., Stouffer, George A., Cavallari, Larisa H.

Polni tekst Polni tekst Polni tekst

CYP2C19 Genotype‐Guided Antiplatelet Therapy After Percutaneous Coronary Intervention in Diverse Clinical Settings od Beitelshees, Amber L., Thomas, Cameron D., Empey, Philip E., Stouffer, George A., Angiolillo, Dominick J., Franchi, Francesco, Tuteja, Sony, Limdi, Nita A., Lee, James C., Duarte, Julio D., Kreutz, Rolf P., Skaar, Todd C., Coons, James C., Giri, Jay, McDonough, Caitrin W., Rowland, Rachel, Stevenson, James M., Thai, Thuy, Vesely, Mark R., Wellen, Jacob T., Johnson, Julie A., Winterstein, Almut G., Cavallari, Larisa H., Lee, Craig R.

Polni tekst Polni tekst Polni tekst

Multi-site investigation of strategies for the implementation of CYP2C19 genotype-guided antiplatelet therapy od Empey, Philip E., Stevenson, James M., Tuteja, Sony, Weitzel, Kristin W., Angiolillo, Dominick J., Beitelshees, Amber L., Coons, James C., Duarte, Julio D., Franchi, Francesco, Jeng, Linda J.B., Johnson, Julie A., Kreutz, Rolf P, Limdi, Nita A., Maloney, Kristin A., Obeng, Aniwaa Owusu, Peterson, Josh F., Petry, Natasha, Pratt, Victoria M., Rollini, Fabiana, Scott, Stuart A., Skaar, Todd C., Vesely, Mark R., Stouffer, George A., Wilke, Russell A., Cavallari, Larisa H., Lee, Craig R.

Polni tekst Polni tekst Polni tekst

Multi-site Investigation of Outcomes with Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy after Percutaneous Coronary Intervention od Cavallari, Larisa H., Lee, Craig R., Beitelshees, Amber L., Cooper-DeHoff, Rhonda M., Duarte, Julio D., Voora, Deepak, Kimmel, Stephen E., McDonough, Caitrin W., Gong, Yan, Dave, Chintan V., Pratt, Victoria M., Alestock, Tameka D., Anderson, R. David, Alsip, Jorge, Ardati, Amer K., Brott, Brigitta C., Brown, Lawrence, Chumnumwat, Supatat, Clare-Salzler, Michael J., Coons, James C., Denny, Joshua C., Dillon, Chrisly, Elsey, Amanda R., Hamadeh, Issam, Harada, Shuko, Hillegass, William B., Hines, Lindsay, Horenstein, Richard B., Howell, Lucius A., Jeng, Linda J.B., Kelemen, Mark D., Lee, Y.M., Magvanjav, Oyunbileg, Montasser, May, Nelson, David R., Nutescu, Edith A., Nwaba, Devon C., Pakyz, Ruth E., Palmer, Kathleen, Peterson, Josh F., Pollin, Toni I., Quinn, Alison H., Robinson, Shawn W., Schub, Jamie, Skaar, Todd C., Smith, Donald M., Sriramoju, Vindhya B., Starostik, Petr, Stys, Tomasz P., Stevenson, James M., Varunok, Nicholas, Vesely, Mark R., Wake, Dyson T., Weck, Karen E., Weitzel, Kristin W., Wilke, Russell A., Willig, James, Zhao, Richard Y., Kreutz, Rolf P., Stouffer, George A., Empey, Philip E., Limdi, Nita A., Shuldiner, Alan R., Winterstein, Almut G., Johnson, Julie A.

Polni tekst Polni tekst Polni tekst